Nearshore Protein (688137.SH): The company's AI-empowered high-throughput wet lab and data package services are still in the early stages of market expansion.

Zhitong Finance APP News, Nearshore Protein (688137.SH) issued an announcement that the company's stock price closed with a cumulative deviation of more than 30% over three consecutive trading days on October 28, October 29, and October 30, 2026. In accordance with the relevant provisions of the Shanghai Stock Exchange Trading Rules and the Shanghai Stock Exchange STAR Market Stock Abnormal Trading Real-Time Monitoring Rules, this constitutes an abnormal fluctuation in stock trading. The company's AI-empowered high-throughput wet lab and data package services are still in the early stage of market expansion. As of the third quarter of 2026, the revenue from related businesses accounted for less than 2% of the company's total operating revenue. Given that the application of AI in the drug R&D industry is still in its infancy, there are risks such as rapid technological iteration, long industry validation cycles, and significant difficulty in commercialization. There is substantial uncertainty regarding the realization of the company's future related revenue and profitability.